Aug 27, 2021
Recommends best option at every level to optimize between Direct and Indirect Coverage, leading to lowered costs, better efficiencies, higher growth.
seen from China
seen from Poland
seen from Malaysia
seen from United States
seen from Sweden
seen from Brazil
seen from Hong Kong SAR China
seen from United States
seen from United States
seen from China
seen from China
seen from United States
seen from Romania
seen from United States
seen from China
seen from United States
seen from United States
seen from Argentina
seen from United States
seen from China
Recommends best option at every level to optimize between Direct and Indirect Coverage, leading to lowered costs, better efficiencies, higher growth.
For Pharma companies post-COVID, HCP contact has reduced drastically. The time is right for e-detailing, using a good analytics platform to drive efficiency.